Aflac Incorporated (NYSE:AFL) Shares Purchased by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC grew its holdings in shares of Aflac Incorporated (NYSE:AFL) by 146.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,018 shares of the financial services provider’s stock after acquiring an additional 19,608 shares during the period. Kingsview Wealth Management LLC’s holdings in Aflac were worth $3,415,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Apollon Wealth Management LLC increased its stake in shares of Aflac by 13.1% in the fourth quarter. Apollon Wealth Management LLC now owns 34,907 shares of the financial services provider’s stock worth $3,611,000 after buying an additional 4,048 shares during the last quarter. Vest Financial LLC grew its holdings in Aflac by 7.1% during the 4th quarter. Vest Financial LLC now owns 826,348 shares of the financial services provider’s stock worth $85,477,000 after acquiring an additional 54,973 shares in the last quarter. Conning Inc. increased its position in shares of Aflac by 2.4% in the 4th quarter. Conning Inc. now owns 350,771 shares of the financial services provider’s stock worth $36,284,000 after purchasing an additional 8,092 shares during the last quarter. Triasima Portfolio Management inc. raised its stake in shares of Aflac by 3.6% in the 4th quarter. Triasima Portfolio Management inc. now owns 41,366 shares of the financial services provider’s stock valued at $4,279,000 after purchasing an additional 1,440 shares in the last quarter. Finally, Global X Japan Co. Ltd. lifted its position in shares of Aflac by 3.6% during the fourth quarter. Global X Japan Co. Ltd. now owns 4,644 shares of the financial services provider’s stock worth $480,000 after purchasing an additional 162 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aflac

In other news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.90% of the company’s stock.

Aflac Stock Up 0.5 %

Aflac stock opened at $103.62 on Monday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a fifty-two week low of $77.01 and a fifty-two week high of $115.50. The firm has a fifty day moving average price of $104.66 and a two-hundred day moving average price of $106.87. The firm has a market cap of $57.56 billion, a price-to-earnings ratio of 10.79, a P/E/G ratio of 2.10 and a beta of 0.99.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, analysts forecast that Aflac Incorporated will post 6.95 earnings per share for the current year.

Aflac Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be given a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a yield of 2.24%. This is a positive change from Aflac’s previous quarterly dividend of $0.50. Aflac’s payout ratio is 20.83%.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Truist Financial lifted their target price on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Barclays lowered their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday. Wells Fargo & Company raised their price target on shares of Aflac from $103.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 14th. Piper Sandler lowered their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research report on Friday. Finally, Evercore ISI cut their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $103.21.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.